Stanley Yeung

Stanley Yeung has extensive experience in the pharmaceutical and clinical research sectors, currently serving as Early Development Asset Lead and Medical Development Director in Oncology at Ipsen since April 2019. Prior roles include Clinical Research Scientist at Karyopharm Therapeutics Inc. and Senior Manager of Global Medical Information and Operations at TESARO, among other positions in clinical pharmacy and pharmacy internships at notable institutions such as Hebrew SeniorLife and Boston Children's Hospital. Stanley Yeung holds a Doctor of Pharmacy (PharmD) degree from the Massachusetts College of Pharmacy and Health Sciences, completed in 2013.